Some Medicare beneficiaries are getting access to weight loss drugs this month through a so-called Bridge program. But ...
Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...
Medicare is rolling out a new program that will provide low-cost access to GLP-1s for weight loss.
Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...
For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...
The Centers for Medicare & Medicaid Services July 1 issued its calendar year 2027 proposed rule for the home health prospective payment system. The rule proposes a 2.4% update, which includes a 3.1% ...
The Trump administration has officially launched its new "bridge" model that brings GLP-1 coverage for weight loss to Medicare beneficiaries. | The Trump administration has officially launched its new ...
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...
See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The U.S. Centers for Medicare and Medicaid Services (CMS) announced a ...
Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...
The Centers for Medicare and Medicaid Services has signaled plans to make cuts to the Medicaid program, saying it wants to put an end to "mounting expenditures," such as housekeeping for ...